Evaluation of Pharmacokinetics and Safety of GSK3196165 in Combination With Methotrexate in Japanese Subjects With Rheumatoid Arthritis

NCT03028467 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: GSK3196165 Dose 1
DRUG: GSK3196165 Dose 2
DRUG: GSK3196165 Dose 3
DRUG: Methotrexate
DRUG: Placebo
DRUG: Folic acid

Sponsor

GlaxoSmithKline